ConductScience.org, home

Paper18596154

Immunotherapy reduces vascular amyloid-beta in PDAPP mice.

Schroeter S and 10 others. J Neurosci, 2008. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Immunotherapy reduces vascular amyloid-beta in PDAPP mice. Papers, record 18596154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18596154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
PubMed
Journal
J Neurosci
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2021-10-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schroeter SSally
2Khan KKaren
3Barbour RRobin
4Doan MMinhtam
5Chen MMing
6Guido TTerry
7Gill DDavinder
8Basi GGuriqbal
9Schenk DDale
10Seubert PPeter
11Games DDora

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amyloid beta-PeptidesMajor topic
Cerebral Amyloid AngiopathyMajor topic
Cerebral HemorrhageMajor topic
Immunization, PassiveMajor topic
Amyloid beta-Protein Precursor
Animals
Antibodies
Cerebral Arteries
Disease Models, Animal
Dose-Response Relationship, Drug
Down-Regulation
Epitopes
Female
Metabolic Clearance Rate
Mice
Mice, Transgenic
Treatment Outcome

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110408445Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature1999https://conductscience.org/library/papers/10408445PubMed
21406936Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.Nature1992https://conductscience.org/library/papers/1406936PubMed
39037091Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9037091PubMed
412765607Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.Neuron2003https://conductscience.org/library/papers/12765607PubMed
512566568Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12566568PubMed
617314293Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.J Neurosci2007https://conductscience.org/library/papers/17314293PubMed
715459438Amyloid angiopathy-related vascular cognitive impairment.Stroke2004https://conductscience.org/library/papers/15459438PubMed
815642916Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.Neurology2005https://conductscience.org/library/papers/15642916PubMed
911140685A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.Nature2000https://conductscience.org/library/papers/11140685PubMed
1016936277Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.Am J Pathol2006https://conductscience.org/library/papers/16936277PubMed
1115588287Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage.J Neuroinflammation2004https://conductscience.org/library/papers/15588287PubMed
1216914852Mice as models: transgenic approaches and Alzheimer's disease.J Alzheimers Dis2006https://conductscience.org/library/papers/16914852PubMed
1312662319Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.Neuropathol Appl Neurobiol2003https://conductscience.org/library/papers/12662319PubMed
1415052274Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.Mol Psychiatry2004https://conductscience.org/library/papers/15052274PubMed
1510932230Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.Nat Med2000https://conductscience.org/library/papers/10932230PubMed
1612640446Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.Nat Med2003https://conductscience.org/library/papers/12640446PubMed
1711140686A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.Nature2000https://conductscience.org/library/papers/11140686PubMed
1816707786Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.J Neurosci2006https://conductscience.org/library/papers/16707786PubMed
1916207868Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.J Neurosci2005https://conductscience.org/library/papers/16207868PubMed
208649554Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.Neurology1996https://conductscience.org/library/papers/8649554PubMed

See all 31 referencesDownload CSV of references

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
42363270Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.Mol Neurodegener2026https://conductscience.org/library/papers/42363270PubMed
42015334Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.Alzheimers Dement2026https://conductscience.org/library/papers/42015334PubMed
41867862Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice.bioRxiv2026https://conductscience.org/library/papers/41867862PubMed
40361247Mouse models of Anti-Aβ immunotherapies.Mol Neurodegener2025https://conductscience.org/library/papers/40361247PubMed
39897432Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery.J Nanotheranostics2023https://conductscience.org/library/papers/39897432PubMed
39794509Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms.Nat Rev Neurol2025https://conductscience.org/library/papers/39794509PubMed
38891941Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease.Int J Mol Sci2024https://conductscience.org/library/papers/38891941PubMed
38225272Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity.Nat Commun2024https://conductscience.org/library/papers/38225272PubMed
37649100Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice.Mol Neurodegener2023https://conductscience.org/library/papers/37649100PubMed
36500385Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimer's Disease.Molecules2022https://conductscience.org/library/papers/36500385PubMed
35340615Structural biology of cell surface receptors implicated in Alzheimer's disease.Biophys Rev2022https://conductscience.org/library/papers/35340615PubMed
35108575Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.Pharmacol Ther2022https://conductscience.org/library/papers/35108575PubMed
33969279Carbon Quantum Dots for Treatment of Amyloid Disorders.ACS Appl Nano Mater2021https://conductscience.org/library/papers/33969279PubMed
32927795Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.Int J Mol Sci2020https://conductscience.org/library/papers/32927795PubMed
31157360Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.Brain2019https://conductscience.org/library/papers/31157360PubMed
29163036Amino-Terminal β-Amyloid Antibody Blocks β-Amyloid-Mediated Inhibition of the High-Affinity Choline Transporter CHT.Front Mol Neurosci2017https://conductscience.org/library/papers/29163036PubMed
28800329Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.J Alzheimers Dis2017https://conductscience.org/library/papers/28800329PubMed
28143566APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice.Mol Neurodegener2017https://conductscience.org/library/papers/28143566PubMed
27239538Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease.Alzheimers Dement (Amst)2016https://conductscience.org/library/papers/27239538PubMed
26551546Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models.Nat Neurosci2015https://conductscience.org/library/papers/26551546PubMed

See all 68 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18596154

GET https://conductscience.org/api/papers/v1/18596154/references?page=2